
Opinion|Videos|August 1, 2024
Therapeutic Response and Disease Progression
Author(s)Justin Oldham, MD, MS
An expert on idiopathic pulmonary fibrosis describes the therapeutic response of standard-of-care treatments and how multidisciplinary care can be optimized when treating patients.
Advertisement
Video content above is prompted by the following:
- How can multidisciplinary care be optimized when treating patients with IPF?
- Describe the therapeutic response and disease progression of patients taking standard of care therapies (pharmacologic and non-pharmacologic).
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
3
Colon Cancer Recurrence Risk Nearly Gone After 6 Years, Study Reveals
4
Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer
5